Globally, STEM scientists are the apex of novel innovation and cutting-edge research and development. While, patents are inextricably linked to innovation, research, and development, both undergraduate and graduate STEM students rarely invent, and those that do almost never invent twice. The thesis of this presentation is three-fold: (1) The understanding, value, benefits, and basics of intellectual property (IP) creation and invention are fundamentally missing in STEM curricula; (2) There are few (if any) incentives for STEM researchers to create and file patent applications within the University environment; and (3) Patent filling assistance programs (pro se) provide pro bono outreach and education to applicants. The key tenants of this presentation are reduced to practice as it relates to pro se patent filings of West Indies inspired invention to the United States Patent and Trademark Office (USPTO) in 2021 and 2022. Three examples of West Indies conceived and awarded IP by a lead inventor domiciled in Anguilla, BWI (Patent Nos. 10,934,168, 11,219,255, and 11,298,375). Further, a permanent patent filling, titled: “Innocuous Sterilant using Hemocyanin and Functionalized Fullerenes with Broad-Spectrum Intracellular and Interstitial Microbiocidal and Radical Scavenging Effects for Packaged Matter, Biologics and Organics including Liquids, Gases, Tissue, Organs, Cells, and Limbs with Copper Mediated Oxygenation for Viability and Preservation” is under review and awaiting a first office action offering broad evidence of origination of IP in the West Indies. As case studies for this presentation, two pieces of IP are examined: The permanent patent and a recently filed provisional application that teaches a minimally invasive and unassisted robotic surgical method for atomic scale manipulation of funtionalized nanoparticles to perform high precision “nano surgery”.
The malaria epidemic was responsible for about 241 million infectious cases and 627,000 deaths worldwide in 2020.[1] This infectious disease, transmitted by the female Anopheles mosquito, is caused by parasites of the genus Plasmodium namely P. falciparum, P. vivax, P. malariae, P. knowlesi, P. ovale curtisi and P. ovale wallikeri.[2,3] Also, malaria is found predominantly in the highlands of Africa which accounts for more than 90% of infections worldwide. While there has been some success in the treatment of malaria, its eradication has been negatively impacted by insecticide and drug resistance. With emergence of thiosemicarbazone as antimalarial agents, the combination of pyridine and amide or thioamide moieties into one scaffold makes for an interesting target.[4]
Loan management is a complex process that coordinates agreements among multiple stakeholders in such a way that each party benefits from the arrangement [2]. At the core of our work there is the Asset Token (ATK) which is a compliant ERC-20 token and used for all financial transactions in our proposed system. With this token in our private blockchain network [1], stakeholders can interact in a digital market. Our work includes a Non-Fungible Vehicle Token (VTK) and represents the physical vehicle. Users has access to the ownership of this NFT which prevents fraudulent transactions.
The burgeoning of small gourmet chocolate boutiques worldwide serves as a key driver for niche and ultra-niche marketing of cocoa (Theobroma cacao L.), branded as (a) geographical indication (b) estate origin or (c) based on unique genetics. Over 90% of the cacao farms globally, are small with an average size between 2 and 5 hectares and can benefit from supplying to the gourmet boutiques.
Brookhaven National Laboratory delivers discovery science and transformative technology to power and secure the nation’s future. Primarily supported by the U.S. Department of Energy’s (DOE) Office of Science, Brookhaven Lab is a multidisciplinary laboratory with seven Nobel Prize-winning discoveries, 37 R&D 100 Awards, and more than 70 years of pioneering research. The laboratory is open to users from all countries and areas of STEM. The workshop will give an introduction to the capabilities of the laboratory, how to access facilities and collaboration tips for working with BNL scientists.
Elsevier is a Netherlands-based academic publishing company specializing in scientific, technical, and medical content. Its products include a number of top-tiered international journals the online citation database Scopus, the SciVal tool for measuring research performance. This publishing house works across all areas of STEM and its products and services also include digital tools for data management, instruction, research analytics and assessment. The company runs several workshops aimed at capacity building with their stakeholders and users.
by clicking any of the buttons below